LONDON, Jan. 15, 2018 -- A new report from Meticulous Research™, titled as ‘Cardiac Pacemaker Devices Market – Global Opportunity Analysis and Industry Forecast (2017-2022)’, cites the global cardiac pacemaker devices market to reach USD 4,629.3 Million by 2022, growing at a CAGR of 3.3% during the forecast period.
“The global cardiac pacemaker devices market is majorly driven by increasing incidence & prevalence of chronic cardiovascular diseases and technological advancements in the area of implantable cardiac pacemakers. In addition, emerging markets and increasing awareness of healthcare further provides a great opportunity for various stakeholders in this market. However, increase in reported cases of cardiac pacemaker malfunctioning & related product recalls restricts the growth of the market to some extent,” mentions Meticulous Research™.
The report also states that, on the basis of end-user, hospitals held the largest share of cardiac pacemaker devices market due to a large pool of patients visiting hospitals and clinics across the globe for diagnosis & treatment of healthcare concerns including cardiovascular diseases.
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=3568
North America (mainly U.S and Canada) currently have the largest share of the cardiac pacemaker devices market, “due to increasing incidence of cardiovascular diseases with rising greying population and increasing burden of hypertension; well-established healthcare system & distribution channel; higher spending on healthcare; and presence of leading players in the market.”
The key players in this market are Medtronic PLC (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Lepu Medical Technology Co Ltd (China), Medico, S.p.A (Italy), Osypka Medical GmbH (Germany), Shree Pacetronix Ltd (India), and Cook Medical Group (U.S.).
Scope of the Report:
Market by Product:
- Cardiac pacemakers
- Implantable cardiac pacemakers
-- Single chamber cardiac pacemakers
-- Dual-chamber cardiac pacemakers
- External pacemakers - Pacing leads
- Pacing analyzers
Market by End-user:
- Hospitals
- Ambulatory surgery centers
- Others
Market by Geography:
- North America
- U.S.
- Canada - Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe - Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific - Rest of World
- Latin America
- Middle East & Africa
Enquiry Before Buying- https://www.meticulousresearch.com/enquire-before-buying/?cp_id=3568
Contact Info:
Viren Shrivastava
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)


Anta Sports Expands Global Footprint With Strategic Puma Stake
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 



